Dystrophin levels as low as 30% are sufficient to avoid muscular dystrophy in the human.

作者: Marcella Neri , Silvia Torelli , Sue Brown , Isabella Ugo , Patrizia Sabatelli

DOI: 10.1016/J.NMD.2007.07.005

关键词: Muscle weaknessDystrophinITGA7Duchenne muscular dystrophySkeletal muscleExonDilated cardiomyopathyMuscular dystrophyBioinformaticsMedicine

摘要: Abstract Mutations in the dystrophin gene give rise to Duchenne and Becker muscular dystrophies (DMD BMD), which both skeletal cardiac muscles are affected, but also X-linked dilated cardiomyopathy (XLDC), a condition characterised by exclusive involvement. XLDC patients with mutations at 5′ end of typically have specific severe transcriptional pathology, absent heart, while reduced levels virtually normal transcript protein present muscle. We now report identification new family detailed characterisation muscle this family, three previously studied families. found that comprised between 29% 57% were sufficient avoid weakness these This information will be help for development therapeutic approaches aimed restoring prevent pathology DMD.

参考文章(34)
Francesco Muntoni, Milena Cau, Antonello Ganau, Rita Congiu, Giuseppina Arvedi, Anna Mateddu, Maria Giovanna Marrosu, Carlo Cianchetti, Giuseppe Realdi, Antonio Cao, Maria Antonietta Melis, BRIEF REPORT - DELETION OF THE DYSTROPHIN MUSCLE-PROMOTER REGION ASSOCIATED WITH X-LINKED DILATED CARDIOMYOPATHY The New England Journal of Medicine. ,vol. 329, pp. 921- 925 ,(1993) , 10.1056/NEJM199309233291304
Arianna Dellavalle, Maurilio Sampaolesi, Rossana Tonlorenzi, Enrico Tagliafico, Benedetto Sacchetti, Laura Perani, Anna Innocenzi, Beatriz G. Galvez, Graziella Messina, Roberta Morosetti, Sheng Li, Marzia Belicchi, Giuseppe Peretti, Jeffrey S. Chamberlain, Woodring E. Wright, Yvan Torrente, Stefano Ferrari, Paolo Bianco, Giulio Cossu, Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells. Nature Cell Biology. ,vol. 9, pp. 255- 267 ,(2007) , 10.1038/NCB1542
Dominic J. Wells, Kim E. Wells, Emmanuel A. Asante, Gaynor Turner, Yoshihide Sunada, Kevin P. Campbell, Frank S. Walsh, George Dickson, Expression of human full-length and minidystrophin in transgenic mdx mice: implications for gene therapy of Duchenne muscular dystrophy Human Molecular Genetics. ,vol. 4, pp. 1245- 1250 ,(1995) , 10.1093/HMG/4.8.1245
Stephanie F. Phelps, Michael A. Hauser, Neil M. Cole, Jill A. Rafael, Richard T. Hinkle, John A. Faulkner, Jeffrey S. Chamberlain, Expression of full-length and truncated dystrophin mini-genes in transgenic mdx mice Human Molecular Genetics. ,vol. 4, pp. 1251- 1258 ,(1995) , 10.1093/HMG/4.8.1251
P Sicinski, Y Geng, A. Ryder-Cook, E. Barnard, M. Darlison, P. Barnard, The molecular basis of muscular dystrophy in the mdx mouse: a point mutation Science. ,vol. 244, pp. 1578- 1580 ,(1989) , 10.1126/SCIENCE.2662404
Michael J. Blankinship, Paul Gregorevic, Jeffrey S. Chamberlain, Gene therapy strategies for Duchenne muscular dystrophy utilizing recombinant adeno-associated virus vectors Molecular Therapy. ,vol. 13, pp. 241- 249 ,(2006) , 10.1016/J.YMTHE.2005.11.001
Mariz Vainzof, Maria Rita Passos-Bueno, Nguyen Thi Man, Mayana Zatz, Absence of correlation between utrophin localization and quantity and the clinical severity in Duchenne/Becker dystrophies American Journal of Medical Genetics. ,vol. 58, pp. 305- 309 ,(1995) , 10.1002/AJMG.1320580403
AlanH. Beggs, Michel Koenig, FrederickM. Boyce, LouisM. Kunkel, Detection of 98% of DMD/BMD gene deletions by polymerase chain reaction Human Genetics. ,vol. 86, pp. 45- 48 ,(1990) , 10.1007/BF00205170
Anton Schmitz, Michael Famulok, Chemical biology: ignore the nonsense. Nature. ,vol. 447, pp. 42- 43 ,(2007) , 10.1038/NATURE05715
F Muntoni, L Wilson, G Marrosu, M G Marrosu, C Cianchetti, L Mestroni, A Ganau, V Dubowitz, C Sewry, A Mutation in the Dystrophin Gene Selectively Affecting Dystrophin Expression in the Heart Journal of Clinical Investigation. ,vol. 96, pp. 693- 699 ,(1995) , 10.1172/JCI118112